Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of June 2024. The report details the status of the Company's Annual General Meeting of Shareholders convened on June 6, 2024.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary event noted is the adjournment of the Annual General Meeting due to a lack of quorum.
Outlook and Management Commentary
- Meeting Adjournment: The Annual General Meeting held on June 6, 2024, was adjourned for one week due to a lack of quorum.
- Reconvened Meeting: The meeting is scheduled to be reconvened on Thursday, June 13, 2024, at 3:00 p.m. (Israel time).
- Location: The meeting will take place at the Company's executive offices at 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel.
- Exhibit Reference: The filing incorporates Exhibit 99.1 by reference into specific registration statements (Form F-3 and Form S-8).
Key Facts for Investor Verification
- Verify the outcome of the reconvened Annual General Meeting scheduled for June 13, 2024.
- Review Exhibit 99.1 referenced in this filing for additional details on the meeting agenda or corporate actions.
- Confirm the Company's financial status through its most recent Form 20-F or quarterly reports, as this filing contains no financial data.